The Maria I. New Children's Hormone Foundation is a New York based non-profit organization. It was created to support the research of the world renowned pediatric endocrinologist, Dr. Maria I. New, and her genetic endocrine group. Dr. New heads the Genetic Endocrinology, Adrenal and Steroid Disorders Group in the Department of Pediatrics at the Mount Sinai College of Medicine.
Dr. New's research focuses on genetic disorders of adrenal steroidogenesis, sexual differentiation and childhood hypertension. Prenatal, genetic diagnosis and treatment of these disorders is a major focus of Dr. New’s research.
Dr. New’s colleagues in the Group are Dr. Madeleine D. Harbison and Dr. Oksana Lekarev. Dr. Harbison’s research focuses on genetic disorders causing gestational growth restriction, [in utero growth retardation (IUGR), small for gestational age (SGA)] and treatment protocols to resolve the associated post-natal growth failure. Dr. Lekarev’s research involves evolving techniques for earlier prenatal diagnosis of steroidogenic disorders and inovative protocols for treating the growth disorders associated with genetic disorders of adrenal and gonadal steroidogenesis.
The Foundation's primary goals are to provide support for:
- Research of Dr. Maria New and her Group focused on better diagnosis, treatment and potentially cures for children suffering from genetic hormonal disorders.
- Travel costs allowing disadvantaged children, afflicted with these specific genetic hormonal disorders, to participate in Dr. New’s Group’s current research protocols
- Education of the young physician-scientists who will be Dr. New’s legacy as innovative leaders to the future in Pediatric Endocrinology
Dr. New’s group provides specialized care for patients with congenital adrenal hyperplasia (CAH), disorders of sexual differentiation, precocious puberty, childhood hypertension, childhood hormone replacement therapy, abnormalities of bone mineral metabolisn, pituitary gland dysfunction, growth hormone deficiency, growth failure associated with in utero growth retardation (IUGR) and Russell-Silver syndrome (RSS), neonatal hypothyroidisn, along with many other hormonal and metabolic disorders, The Maria New Children's Hormone Foundation is a source of hope for a healthier future of our children.
Dr. New's research and groundbreaking work in nonclassical congenital adrenal hyperplasia was featured in the New York Times, Science Times, on July 7, 2009. http://www.nytimes.com/2009/07/07/health/07endo.html